Join the Ubrelvy group to help and get support from people like you.
Ubrelvy News
Understanding Headaches: Types, Triggers And New Treatments
SUNDAY, Sept. 14, 2025 — Everyone gets headaches, but not all headaches are the same. For some, they’re a quick inconvenience. For others, they can be intense, long-lasting and even disabling, disr...
Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms
WEDNESDAY, May 14, 2025 – Migraines don’t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What’s more, those n...
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...
FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine
DUBLIN, Dec. 23, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for...